Predictive Role of Biomarkers in COVID-19 Mortality
Authors:
Open Access
- 24 January 2023
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e34173
Abstract
Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in high mortality among patients in critical intensive care units. Hence, identifying mortality markers in the follow-up and treatment of these patients is essential. This study aimed to evaluate the relationships between mortality rates in patients with COVID-19 and the neutrophil/lymphocyte ratio (NLR), derived NLR (dNLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), systemic inflammation response index (SII), and systemic inflammatory response index (SIRI). Methodology In this study, we assessed 466 critically ill patients diagnosed with COVID-19 in the adult intensive care unit of Kastamonu Training and Research Hospital. Age, gender, and comorbidities were recorded at the time of admission along with NLR, dNLR, MLR, PLR, SII, and SIRI values from hemogram data. Acute Physiology and Chronic Health Evaluation II (APACHE II) scores and mortality rates over 28 days were recorded. Patients were divided into survival (n = 128) and non-survival (n = 338) groups according to 28-day mortality. Results A statistically significant difference was found between leukocyte, neutrophil, dNLR, APACHE II, and SIRI parameters between the surviving and non-surviving groups. A logistic regression analysis of independent variables of 28-day mortality identified significant associations between dNLR (p = 0.002) and APACHE II score (p < 0.001) and 28-day mortality. Conclusions Inflammatory biomarkers and APACHE II score appear to be good predictive values for mortality in COVID-19 infection. The dNLR value was more effective than other biomarkers in estimating mortality due to COVID-19. In our study, the cut-off value for dNLR was 3.64.Keywords
This publication has 22 references indexed in Scilit:
- The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patientsInternational Immunopharmacology, 2020
- Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19Journal of Infection, 2020
- Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19Cells, 2020
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetesBMJ Open Diabetes Research & Care, 2020
- Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive studySignal Transduction and Targeted Therapy, 2020
- [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].2020
- Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei ProvinceChinese Medical Journal, 2020
- Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developmentsVeterinary Quarterly, 2020
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research, 2014
- A derived neutrophil to lymphocyte ratio predicts survival in patients with cancerBritish Journal of Cancer, 2012